A Phase 2a, Randomized, Partially-blind, Placebo-controlled Study to Assess the Efficacy, Safety, and Pharmacokinetics of 24 Weeks of Treatment With Multiple Doses of JNJ-56136379 as Monotherapy and in Combination With a Nucleos(t)ide Analog in Subjects With Chronic Hepatitis B Virus Infection (JADE)
21st May 2018 - ongoing
Status: Active
Specialism: Liver.
Team: Dr Stephen Ryder.
People
Photo | Name | Bio |
---|---|---|
![]() |
Dr Stephen Ryder |
Publications
Title |
---|
Grants
Title | Amount |
---|